Specialty medical device maker Nevro (NYSE: NVRO) didn't make for an inspiring investment on Thursday. Its stock price dipped marginally following the company's release of its fourth-quarter earnings report Wednesday. That contrasted with the S&P 500 index, which gained nearly 2.5%. For the fourth quarter, ...
motleyfoolusx:nvro